Structure Database (LMSD)
Common Name
13,14-dihydro-15-keto-tetranor Prostaglandin D2
Systematic Name
9S-hydroxy-11,15-dioxo-2,3,4,5-tetranor-prostanoic acid
Synonyms
- 3-[(1R,2R,5S)-5-hydroxy-3-oxo-2-(3-oxooctyl)cyclopentyl]propanoic acid
LM ID
LMFA03010245
Formula
Exact Mass
Calculate m/z
298.178025
Sum Composition
Status
Curated
3D model of 13,14-dihydro-15-keto-tetranor Prostaglandin D2
Please note: Where there are chiral atoms but the stereochemistry is undefined, the 3D model takes an arbitrary conformation
Classification
Biological Context
A common metabolic pathway for several prostaglandins (PGs), including prostaglandin D2 (PGD2), involves the reduction of the double bond between C-13 and C-14 and oxidation of the hydroxyl group at C-15, producing 13,14-dihydro-15-keto PGs. The removal of four carbons at the α-terminus and oxidation of the terminal ω-carbon produces the abundant urinary metabolites, including tetranor-PGDM.1 13,14-dihydro-15-keto-tetranor PGD2 is a potential metabolite of PGD2. It would be produced from the known metabolite 13,14-dihydro-15-keto PGD2, which is a known agonist for the CRTH2/DP2 receptor.2
This information has been provided by Cayman Chemical
References
References
Taxonomy Information
String Representations
InChiKey (Click to copy)
CIXGXJHOQWHINC-NFAWXSAZSA-N
InChi (Click to copy)
InChI=1S/C16H26O5/c1-2-3-4-5-11(17)6-7-12-13(8-9-16(20)21)15(19)10-14(12)18/h12-13,15,19H,2-10H2,1H3,(H,20,21)/t12-,13-,15+/m1/s1
SMILES (Click to copy)
[C@H]1(CCC(=O)CCCCC)C(=O)C[C@H](O)[C@@H]1CCC(=O)O
Other Databases
Calculated Physicochemical Properties
Heavy Atoms
21
Rings
1
Aromatic Rings
Rotatable Bonds
10
Van der Waals Molecular Volume
309.03
Topological Polar Surface Area
91.67
Hydrogen Bond Donors
2
Hydrogen Bond Acceptors
5
logP
2.63
Molar Refractivity
78.38
Admin
Created at
21st Nov 2024
Updated at
21st Nov 2024